TOKYO (AP) — Japan’s Cabinet approved on Friday a record 56 trillion yen ($490 billion) stimulus package, including cash handouts and aid to ailing businesses, to help the economy out of the doldrums worsened by the coronavirus pandemic.

“The package has more than enough content and scale to deliver a sense of security and hope to the people,” Prime Minister Fumio Kishida told reporters in announcing the plan earlier in the day.

“We want to support those people who are suffering because of the coronavirus, while steering our nation’s sorely damaged economy back to health,” Kishida said about the latest package.

The proposal won Cabinet approval in the evening, according to the prime minister’s office.

It still needs parliamentary approval.

Kishida has promised speedy action, and parliament will convene next month, he said.

The plan includes doling out 100,000 yen ($880) each in monetary assistance to those 18 years or younger, and aid for businesses whose sales plummeted because of coronavirus measures.

Japan has never had a full lockdown during the pandemic and infections remained relatively low, with deaths related to COVID-19 at about 18,000 people.

But the world’s third largest economy was already stagnating before the pandemic hit.

Some analysts say the economy is unlikely to rebound until next year.

Japan’s economy contracted at an annual rate of 3% in the July-September period, largely because of weak consumer spending.

Under the government’s “state of emergency,” some restaurants closed or limited their hours, and events and theaters restricted crowd sizes for social distancing.

Shortage of computer chips and other auto parts produced in other Asian nations that had severe outbreaks and strict lockdowns has hurt production at Japan’s automakers, including Toyota Motor Corp., an economic mainstay.

Analysts say the scale of the latest package will push Japan’s debt higher since it will be financed by issuing bonds.

Japan has also promised to earmark spending for vaccine research after facing criticism over being dependent on imports for coronavirus vaccines. It has so far approved vaccines from Pfizer, Moderna and AstraZeneca.

Source: AP NEWS,19/11/2021

Last Updated on 19.11.2021 by iskova